Veterinary associations recommend regular parasite control and diagnostics to prevent transmission. However, parasiticides face growing scrutiny over environmental and health concerns. With resistance increasing, changemakers are developing innovative solutions, ranging from new treatments to advanced diagnostics and targeted delivery, ensuring long-term protection for animals and humans.
- Market differentiation – demonstrating value of novel products in a crowded market
- Adoption hurdles – balancing efficacy, cost, and stewardship to drive uptake
Session Topics:
Livestock
Companion
Biopharma
Diagnostics
Speaker(s):
Moderator
Panellists

Pieter-Jan Serreyn
Technical Director
AnimalHealthEurope

Andreas Kastenbauer
Partner
MIG Capital

Dawn Howard
CEO
NOAH

Ashwani Sharma
Co-Founder and Co-CEO
ASTRA Therapeutics
Time:
2:40pm - 3:10pm
Agenda Track No.:
Track 5
Session Type:
General Session (Presentation)
Force Inline Description:
0